ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3202

Clinical and Ultrasonographic Evaluation of Joint Involvement in Patients with Systemic Sclerosis

María Victoria Martire1, Priscila Marcaida2, Santiago Scarafia3, Gloria Crespo2, Anastasia Secco4, Lida Santiago2 and Marta Mamani2, 1Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 2Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina, 3Hospital Bernardino Rivadavia, CABA, Argentina, 4Hospital Bernardino Rivadavia, Buenos Aires, Argentina

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Systemic sclerosis and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Imaging of Rheumatic Diseases III: Crystal Arthritis, Osteoarthritis, Connective Tissue Disease and Vasculitis

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Systemic sclerosis is a multisystem disease characterized by the development of microangiopathy and subsequent fibrosis of skin and internal organs. The joint involvement is common, but its prevalence and characteristics differ in the literature. Traditionally, it has been assessed by clinical examination, which may underestimate the presence of synovitis and erosions. Objective: To evaluate the characteristics of joint involvement in a cohort of patients with systemic sclerosis assessed by clinimetric and ultrasonographic (US) measures.

Methods:  Observational cross-sectional study. Consecutive patients with systemic sclerosis according to ACR-EULAR 2010 criteria were included. Acute phase reactants (erythrocyte sedimentation rate and C-reactive protein), immunology laboratory, rheumatoid factor and antiCCP were measured the day of clinical examination. Disease activity was measured by DAS28, hands’ functionality was assessed by Duruöz Index and modified Kapandji Test, extension of cutaneous involvement by modified Rodnan Score and disability by HAQ-A. All US examinations were performed by an experienced rheumatologist, blinded to clinical and laboratory data. The US evaluation included examination in grayscale and power Doppler with a linear transducer (10-18MhZ) in the longitudinal and transverse sections of: radiocarpal and intracarpian joint, second to fifth metacarpophalangeal joint, tibiotalar joint, 1st to 6th wrist tendon extensor compartment, 1st to 5th digital flexor tendon, Achilles tendon, peroneal tendons, posterior tibialis tendon and tibialis anterior tendon, all bilaterally. For descriptive statistics, continuous variables were described as median (IQR) and categorical variables as percentages. To analyze the differences between the groups with and without ultrasound findings, Mann Whitney test was used for continuous variables, and Fisher exact test for categorical variables. It was considered as significant a p value < 0.05.

Results: 40 consecutive patients with systemic sclerosis were included. Median age was: 53 (IQR 45-59), 87.5% were women. The median time since the first not Raynaud manifestation was 4 years (IQR 2-6). The 72.5% of patients had limited scleroderma, Barnet subtype 1, 77.5% had Raynaud, 50% of patients reported suffering from arthralgia and only 4 patients arthritis, 35% (n = 14) had pitting and 17.5% (n = 7) active digital ulcers. Only 1 patient had a history of amputation and 2 had calcinosis. The median Duruöz index was 12.7 (SD 14.3), Kapandji Test 80 (SD 23), HAQ 0.79 (SD 0.83) and DAS28: 2.77 (IQR: 2.18- 3.34). The US findings were: 47.5% (n = 19) of patients presented at least one finding by ultrasound, 32.5% (n = 13) proliferative synovitis grade II in the radiocarpal joint and 2.5% (n = 1) Grade III. Only 2 patients had PD positive grade II. At the tibiotalar joint, only 2 patients had moderate synovitis. 15% (n = 6) had extensor compartment tenosynovitis and 30% (n = 12) digital flexor tenosynovitis. The 42, 5% of patients (n = 17) had tenosynovitis and/or tendinopathy in tibialis anterior tendon, posterior tibialis tendon, peroneal tendons and Achilles tendon. 12.5% (n = 5) had erosions in styloid process (n = 4) and 2nd metacarpophalangeal (n = 1). No statistically significant differences were found between the groups with and without ultrasound findings regarding the following variables: Median HAQ, DAS28, Score Rodnan, Duruöz Index and Kapandji Test, anti centromere and Scl-70 antibodies, RF, acute phase reactants, VAS, disease duration, age or treatments (p> 0.05).

Conclusion: The joint involvement in systemic sclerosis is frequent, evaluated both clinically and by ultrasound. This manifestation should be considered in daily care in patients with systemic sclerosis.


Disclosure: M. V. Martire, None; P. Marcaida, None; S. Scarafia, None; G. Crespo, None; A. Secco, None; L. Santiago, None; M. Mamani, None.

To cite this abstract in AMA style:

Martire MV, Marcaida P, Scarafia S, Crespo G, Secco A, Santiago L, Mamani M. Clinical and Ultrasonographic Evaluation of Joint Involvement in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-and-ultrasonographic-evaluation-of-joint-involvement-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-and-ultrasonographic-evaluation-of-joint-involvement-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology